Dementia prevention remains one of the most urgent challenges in aging research. A long-term follow-up of older adults from the well-known ACTIVE trial now offers a fresh perspective on whether structured brain training can delay the onset of Alzheimer’s disease and related conditions.
The findings, published in “Alzheimer’s & Dementia: Translational Research & Clinical Interventions,” point to one specific type of cognitive training as a possible factor in lowering dementia risk over two decades.
What the ACTIVE Trial Set Out to Test
Launched in 1999, the ACTIVE (Advanced Cognitive Training for Independent and Vital Elderly) trial enrolled 2,832 adults aged 74 on average. Participants were randomly assigned to one of four groups:
1. Processing speed training
2. Memory training
3. Reasoning training
4. No-contact control group
Each training arm completed 10 sessions over five to six weeks. In addition, half of those who finished the program were randomly selected to receive booster sessions at 11 and 35 months.
The trial formally ended in 2010. Results showed that each intervention preserved gains in its targeted cognitive ability for up to five years. Memory improvements faded by year 10, while other benefits persisted longer.
Linking Brain Training to Medicare Records
Freepik | New evidence from the ACTIVE trial suggests brain training may ward off Alzheimer’s.
To assess long-term outcomes, researchers led by Marilyn Albert, PhD, of Johns Hopkins School of Medicine, analyzed Medicare claims data through 2019. The team linked records for 2,021 participants, representing 72.1% of the original group. Beneficiaries enrolled in Medicare Advantage were excluded.
Over 20 years, 77% of participants died, with a mean age at death of 84. The primary outcome was a Medicare claim indicating Alzheimer’s disease or a related dementia. Diagnoses were not confirmed through specialized clinical testing.
Key Findings on Dementia Risk
Across the entire sample, memory and reasoning training showed a trend toward lower dementia diagnoses compared with the control group. However, these associations did not reach statistical significance.
Only one subgroup demonstrated a meaningful long-term link:
Participants who received processing speed training plus booster sessions had a lower dementia risk
– Hazard ratio: 0.75
– 95% confidence interval: 0.59–0.95
Among control participants, 48.7% (239 of 491) had a Medicare dementia claim. In contrast, 39.77% (105 of 264) of those who completed speed training with boosters had such a claim.
Importantly, individuals who completed speed training without booster sessions did not show a reduced dementia risk.
Albert and colleagues noted their surprise that memory and reasoning training did not achieve statistical significance in any analysis.
Why Speed Training May Stand Apart
Processing speed training in the ACTIVE trial was adaptive. Tasks increased in difficulty based on participant performance. Memory and reasoning programs did not adjust in this way.
Researchers suggested that adaptive training may have triggered broader brain activation. This difference, they wrote, could explain why the speed-training arm showed distinct long-term associations.
According to Richard Hodes, MD, director of the National Institute on Aging, which funded the research, “The findings reported here suggest that moderate cognitive training could delay the onset of dementia over subsequent years.” He added that this “promising lead may move the field into developing effective interventions to delay or prevent the onset of dementia.”
Important Limitations to Consider
Freepik | Future cognitive training for seniors should prioritize visual speed and multitasking research.
Despite encouraging signals, several experts urged caution.
Baptiste Leurent, PhD, from the UCL Department of Statistical Science in London, pointed out potential sources of bias, including missing data and high mortality. He emphasized that none of the primary analyses showed significant differences between the training groups and the controls. A single positive subgroup finding, he wrote on the U.K. Science Media Centre website, is generally not sufficient to confirm effectiveness.
Susan Kohlhaas, PhD, of Alzheimer’s Research UK, added that dementia diagnoses were based on health records rather than specialist clinical evaluations. As a result, it remains unclear whether the intervention altered underlying disease processes or affected specific dementia subtypes.
These factors limit the confidence with which the findings can be applied to broader populations.
Implications for Dementia Prevention
Co-author George Rebok, PhD, of the Johns Hopkins Bloomberg School of Public Health, stated that the results support continued development and refinement of cognitive training programs for older adults. In particular, interventions targeting visual processing speed and divided attention deserve closer study.
Rebok also noted that combining structured cognitive training with lifestyle interventions may delay dementia onset. That possibility, however, requires additional research.
The Medicare-linked review of the ACTIVE trial does not confirm a proven way to prevent dementia. Memory and reasoning training showed no significant long-term protection. However, adaptive processing speed training combined with booster sessions was associated with fewer dementia diagnoses over 20 years.
These findings point to a focused area for continued research on structured cognitive training and its potential role in delaying dementia onset.
